Creative Planning
BBNX

Creative Planning’s Beta Bionics BBNX Stock Holding History

Creative Planning’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$726K Buy
46,353
+14,365
+45% +$171K ﹤0.01% 2897
2026
Q1 		$321K Buy
31,988
+25,290
+378% +$374K ﹤0.01% 3377
2025
Q4 		$204K Buy
+6,698
New +$179K ﹤0.01% 3537

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Creative Planning's BBNX Position: Q2 2026 in Review

Creative Planning increased its Beta Bionics (BBNX) stake by 45% in Q2 2026, buying an estimated $171K and bringing the position to 46,353 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

Creative Planning first reported a position in BBNX in Q4 2025 and has held it in 3 quarters since. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Creative Planning held 46,353 shares of Beta Bionics worth $726K as of Q2 2026.
  • Creative Planning bought 14,365 Beta Bionics shares in Q2 2026, an estimated $171K.
  • Beta Bionics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2897 holding.
  • Creative Planning first reported a position in Beta Bionics in Q4 2025 and has held it in 3 quarters since.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.